Earnings History Data for Regulus Therapeutics (RGLS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Regulus Therapeutics

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
21-03-2024	AH		RGLS	Regulus Therapeutics	48.00	-0.40	-0.40	0.00	Regulus Therapeutics GAAP EPS of -$0.40 in-line [3/21/2024 4:46 PM]	2.66	-0.12 (-4.32%)	2.84	0.06 (2.16%)	0.77 - 3.79	628,009	18,160,000	14,527
Regulus Therapeutics GAAP EPS of -$0.40 in-line [3/21/2024 4:46 PM]
08-08-2023	AH		RGLS	Regulus Therapeutics	27.00	-0.37	-0.39	0.00	Regulus Therapeutics GAAP EPS of -$0.37 beats by $0.04 [8/8/2023 5:29 PM]	1.35	0.02 (1.50%)	0.0	0.0 (0.00%)	0.76 - 2.40	3,542	10,000	0
Regulus Therapeutics GAAP EPS of -$0.37 beats by $0.04 [8/8/2023 5:29 PM]
10-11-2022	AH	4:10 PM ET (Nov 10)	RGLS	Regulus Therapeutics Inc.	26.20	-0.50	-0.50	1.00	Regulus Therapeutics GAAP EPS of -$0.50 [11/10/2022 4:20 PM]	1.64	0.01 (0.92%)	1.83	0.21 (12.62%)	1.33 - 4.37	23,744	50,000	101
Regulus Therapeutics GAAP EPS of -$0.50 [11/10/2022 4:20 PM] Regulus Therapeutics Reports Third Quarter 2022 Financial Results and Recent Updates [Nov-10-22 04:05PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	RGLS	Regulus Therapeutics Inc.	25.40	-0.50	-0.46	-0.80		1.74	0.09 (5.51%)	1.60	-0.05 (-3.03%)	1.42 - 8.72	72,855	200,000	1,329
Regulus Therapeutics GAAP loss per share narrows [8/11/2022 4:14 PM]
12-05-2022	AH	4:05 PM ET (May 12)	RGLS	Regulus Therapeutics Inc.	25.08	-0.05	-0.05	-0.08	Regulus Therapeutics GAAP EPS of -$0.05 [5/12/2022 4:09 PM]	0.22	-0.03 (-10.42%)	0.20	-0.04 (-17.30%)	0.16 - 1.48	3,049,842	7,250,000	89,227
Regulus Therapeutics GAAP EPS of -$0.05 [5/12/2022 4:09 PM] Regulus Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) [May-11-22 08:00AM] Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug [May-12-22 10:20AM] Regulus Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates [May-12-22 04:05PM]
10-03-2022	AH	4:05 PM ET (Mar 10)	RGLS	Regulus Therapeutics Inc.	42.14	-0.07	-0.05	-0.03	Regulus Therapeutics GAAP EPS of -$0.07 [3/10/2022 4:10 PM]	0.2861	-0.02 (-5.26%)	0.30	-0.01 (-1.66%)	0.19 - 2.32	848,439	2,480,000	20,357
Regulus Therapeutics GAAP EPS of -$0.07 [3/10/2022 4:10 PM] Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Updates [Mar-10-22 04:05PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	RGLS	Regulus Therapeutics Inc.	41.61	-0.10	-0.07	-0.04	Regulus Therapeutics EPS misses by $0.02, revenue in-line [11/10/2021 4:20 PM]	0.4179	-0.02 (-4.30%)	0.43	-0.01 (-1.53%)	0.42 - 2.32	1,212,497	2,060,000	44,188
Regulus Therapeutics EPS misses by $0.02, revenue in-line [11/10/2021 4:20 PM] Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates [Nov-10-21 04:05PM] Regulus (RGLS) Reports Q3 Loss, Lags Revenue Estimates [Nov-10-21 05:45PM]
10-08-2021	AH	4:05 PM ET (Aug 10)	RGLS	Regulus Therapeutics Inc.	54.21	-0.08	-0.08	-0.23	Regulus Therapeutics EPS in-line [8/10/2021 4:28 PM]	0.72	-0.01 (-1.95%)	0.77	0.04 (4.86%)	0.42 - 2.32	1,018,252	890,000	128,663
Regulus Therapeutics EPS in-line [8/10/2021 4:28 PM] Regulus Therapeutics Reports Second Quarter 2021 Financial Results and Recent Updates [Aug-10-21 04:05PM] Regulus (RGLS) Reports Q2 Loss, Misses Revenue Estimates [Aug-10-21 05:55PM]
13-05-2021	AH	4:05 PM ET (May 13)	RGLS	Regulus Therapeutics Inc.	64.18	-0.08	-0.09	-0.25	Regulus Therapeutics EPS beats by $0.01 [5/13/2021 4:35 PM]	0.8899	0.07 (8.52%)	0.88	0.06 (7.68%)	0.42 - 2.32	1,319,994	1,840,000	33,636
Regulus Therapeutics EPS beats by $0.01 [5/13/2021 4:35 PM] Regulus Therapeutics, Inc. to Host Earnings Call [May-13-21 03:15PM] Regulus Therapeutics Reports First Quarter 2021 Financial Results and Recent Updates [May-13-21 04:07PM] Regulus (RGLS) Reports Q1 Loss, Misses Revenue Estimates [May-13-21 05:35PM] Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit [May-14-21 04:07PM]
09-03-2021	AH	4:05 PM ET (Mar 9)	RGLS	Regulus Therapeutics Inc.	51.00	-0.03	-0.10	0.00	Regulus Therapeutics EPS of -$0.03 [3/9/2021 4:29 PM]	1.35	-0.02 (-1.46%)	1.38	0.01 (0.73%)	0.42 - 1.97	1,650,149	2,286,586	128,157
Regulus Therapeutics EPS of -$0.03 [3/9/2021 4:29 PM] Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates [Mar-09-21 04:07PM] Investors Who Bought Regulus Therapeutics (NASDAQ:RGLS) Shares A Year Ago Are Now Up 101% [Mar-10-21 04:03AM]
13-08-2020	AH		RGLS	Regulus Therapeutics Inc.	19.54	-0.23	-0.20	-0.30	Regulus Therapeutics EPS misses by $0.12 [8/13/2020 4:39 PM]	0.6250	-0.01 (-2.11%)	0.64	0.0 (0.23%)	0.43 - 1.74	496,557	1,499,364	43,237

14-05-2020	AH		RGLS	Regulus Therapeutics Inc.	20.99	-0.25	-0.01	-0.31	Regulus Therapeutics EPS misses by $0.13 [5/14/2020 4:24 PM]	0.5990	-0.06 (-9.24%)	0.60	0.0 (0.17%)	0.43 - 1.74	491,610	606,682	4,801